Skip to Content

Invesco Advantage International R QMGRX

Medalist Rating as of | See Invesco Investment Hub
  • NAV / 1-Day Return 10.81  /  −0.09 %
  • Total Assets 32.5 Mil
  • Adj. Expense Ratio
    1.440%
  • Expense Ratio 1.440%
  • Distribution Fee Level Above Average
  • Share Class Type Retirement, Medium
  • Category Foreign Large Blend
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 4.75%
  • Turnover 196%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:16 PM GMT+0

Morningstar’s Analysis QMGRX

Will QMGRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Invesco Advantage International R's recent fee hike leads to a downgrade to this strategy's Morningstar Medalist Rating to Negative from Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings QMGRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Msci Eafe Lowvol Tr Swap (Leg A)

8.22 2.6 Mil

S&P Canada 60 Index Mar14

7.88 2.5 Mil

Canadian Dollar Mar24

7.66 2.4 Mil
Derivative

United States Treasury Bills 0%

4.83 1.5 Mil
Government

United States Treasury Bills 0%

4.35 1.4 Mil
Government

Msci Emerg Low Vol Tr Swap (Leg A)

3.52 1.1 Mil

Futures Cash Collateral & Vm

3.37 1.1 Mil
Cash and Equivalents

Novo Nordisk A/S Class B

2.68 837,021
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd ADR

2.57 801,338
Technology

Novartis AG Registered Shares

2.56 798,327
Healthcare